JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The Journal of Clinical Psychopharmacology (ISSN 0271-0749) is a prestigious bi-monthly peer-reviewed publication issued by Lippincott Williams & Wilkins in the United States, dedicated to advancing the field of clinical psychopharmacology. As an indexed SCI journal, it typically maintains an impact factor ranging between 2.5 and 3.0 and is categorized within the third or fourth quartile of the Chinese Academy of Sciences journal ranking in the medical or pharmacological domains. The journal serves as a critical resource for clinicians and researchers by publishing rigorous studies on the clinical application of psychotropic agents, encompassing pharmacodynamics, pharmacokinetics, adverse effects, and drug interactions across a spectrum of mental health disorders, including depression, schizophrenia, and anxiety. Although it operates as a non-open access publication with stringent editorial standards, it remains a highly regarded reference for evaluating the clinical applicability and ethical considerations of psychopharmacological interventions, thereby fostering robust dialogue between clinical practice and scientific inquiry in the treatment of psychiatric conditions.